SUBSCRIBE
SUBSCRIBE
News   Deals

Novo Nordisk A/S, Eli Lilly and Company, And Novartis AG Said to Bid for Ascendis Pharma A/S; Offer is Rumored to be About $400 Million

August 2, 2010 | 
1 min read
Bloomberg -- Novo Nordisk A/S, Novartis AG’S Sandoz and Eli Lilly & Co. are among bidders for Ascendis Pharma A/S of Denmark, a person with knowledge of the matter said.
Mergers & acquisitions Europe
Eli Lilly and Company Novo Nordisk Novartis
MORE ON THIS TOPIC
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong